Cannabidiol Inhibits the Proliferation and Invasiveness of Prostate Cancer Cells.
Journal
Journal of natural products
ISSN: 1520-6025
Titre abrégé: J Nat Prod
Pays: United States
ID NLM: 7906882
Informations de publication
Date de publication:
22 09 2023
22 09 2023
Historique:
medline:
25
9
2023
pubmed:
14
9
2023
entrez:
13
9
2023
Statut:
ppublish
Résumé
Prostate cancer is the fifth leading cause of cancer death in men, responsible for over 375,000 deaths in 2020. Novel therapeutic strategies are needed to improve outcomes. Cannabinoids, chemical components of the cannabis plant, are a possible solution. Preclinical evidence demonstrates that cannabinoids can modulate several cancer hallmarks of many tumor types. However, the therapeutic potential of cannabinoids in prostate cancer has not yet been fully explored. The aim of this study was to investigate the antiproliferative and anti-invasive properties of cannabidiol (CBD) in prostate cancer cells
Identifiants
pubmed: 37703852
doi: 10.1021/acs.jnatprod.3c00363
pmc: PMC10521019
doi:
Substances chimiques
Cannabidiol
19GBJ60SN5
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2151-2161Références
Oncogene. 2018 Dec;37(49):6368-6382
pubmed: 30061636
Psychopharmacology (Berl). 2021 Jan;238(1):9-28
pubmed: 33221931
Int J Cancer. 2014 Jun 1;134(11):2534-46
pubmed: 24293211
Biomolecules. 2019 Jul 25;9(8):
pubmed: 31349651
Cancer Res. 2005 Mar 1;65(5):1635-41
pubmed: 15753356
Biochem Pharmacol. 2010 Apr 1;79(7):955-66
pubmed: 19914218
Biomed Pharmacother. 2021 Oct;142:112007
pubmed: 34385107
Nat Rev Cancer. 2009 Mar;9(3):153-66
pubmed: 19238148
Prostate. 2019 Feb;79(2):151-159
pubmed: 30242861
Carcinogenesis. 1993 May;14(5):993-9
pubmed: 8389257
Eur J Cancer. 2009 Jan;45(1):174-82
pubmed: 19056257
J Pharmacol Exp Ther. 2008 Jun;325(3):1007-15
pubmed: 18354058
J Mol Med (Berl). 2012 Aug;90(8):925-34
pubmed: 22231745
Biochimie. 2019 Oct;165:229-234
pubmed: 31401189
PLoS One. 2013 Oct 21;8(10):e76918
pubmed: 24204703
Mol Biol Rep. 2023 May;50(5):4039-4047
pubmed: 36853473
Cancer Lett. 2019 Apr 10;447:12-23
pubmed: 30660647
Crit Rev Oncol Hematol. 2021 Jan;157:103199
pubmed: 33316419
BMJ. 2019 Apr 4;365:l1141
pubmed: 30948383
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Steroid Biochem Mol Biol. 2021 Jun;210:105876
pubmed: 33722705
Br J Pharmacol. 2015 Oct;172(20):4790-805
pubmed: 26218440
Breast Cancer Res Treat. 2011 Aug;129(1):37-47
pubmed: 20859676
J Pharmacol Exp Ther. 2017 Jan;360(1):215-224
pubmed: 27821713
Nat Rev Clin Oncol. 2019 Mar;16(3):185-204
pubmed: 30514977
Cells. 2021 Feb 05;10(2):
pubmed: 33562819
Cancer Sci. 2022 Apr;113(4):1235-1249
pubmed: 34971020
Br J Pharmacol. 2007 Mar;150(5):613-23
pubmed: 17245363
Cancer Cell. 2005 Sep;8(3):179-83
pubmed: 16169463
FASEB J. 2012 Apr;26(4):1535-48
pubmed: 22198381
Prostate Cancer Prostatic Dis. 2016 Sep;19(3):248-57
pubmed: 27324222
Cancer Res. 2006 Jul 1;66(13):6615-21
pubmed: 16818634
Curr Drug Saf. 2011 Sep 1;6(4):237-49
pubmed: 22129319
Front Pharmacol. 2017 Mar 24;8:144
pubmed: 28392768
Phytomedicine. 2014 Apr 15;21(5):631-9
pubmed: 24373545
PLoS One. 2020 Feb 12;15(2):e0228909
pubmed: 32049991
Mol Oncol. 2015 Apr;9(4):906-19
pubmed: 25660577
Pharmacol Res. 2023 Mar;189:106683
pubmed: 36736415
Cancer Res. 2019 Mar 15;79(6):1019-1031
pubmed: 30808672
Biomolecules. 2022 Jun 20;12(6):
pubmed: 35740979
Int J Mol Sci. 2020 Mar 31;21(7):
pubmed: 32244518
Int J Mol Sci. 2020 Aug 29;21(17):
pubmed: 32872551
Cancers (Basel). 2022 Feb 24;14(5):
pubmed: 35267489
Cancer Res. 2013 Mar 1;73(5):1559-69
pubmed: 23243024
Cancers (Basel). 2021 Nov 12;13(22):
pubmed: 34830821
Anticancer Res. 2011 Nov;31(11):3799-807
pubmed: 22110202
Oncogene. 2002 Jan 3;21(1):128-39
pubmed: 11791183
Oncogene. 2011 Jan 13;30(2):142-52
pubmed: 20838378
Br J Cancer. 2022 Jul;127(1):1-13
pubmed: 35277658
Int J Cancer. 2015 Oct 15;137(8):1855-69
pubmed: 25903924
Int J Mol Sci. 2020 Jan 25;21(3):
pubmed: 31991773
Sci Rep. 2020 Nov 26;10(1):20622
pubmed: 33244087
Oncotarget. 2019 Jan 01;10(1):45-59
pubmed: 30713602
Leukemia. 2003 Mar;17(3):590-603
pubmed: 12646949
Br J Pharmacol. 2016 Jun;173(12):1899-910
pubmed: 27077495
Br J Pharmacol. 2013 Jan;168(1):79-102
pubmed: 22594963
Cell Death Dis. 2015 Jan 15;6:e1601
pubmed: 25590811
Br J Pharmacol. 2019 May;176(10):1455-1469
pubmed: 29981240